ethylisopropylamiloride has been researched along with Stomach Neoplasms in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosogi, S | 1 |
| Miyazaki, H | 1 |
| Nakajima, K | 1 |
| Ashihara, E | 1 |
| Niisato, N | 1 |
| Kusuzaki, K | 1 |
| Marunaka, Y | 1 |
1 other study available for ethylisopropylamiloride and Stomach Neoplasms
| Article | Year |
|---|---|
An inhibitor of Na(+)/H(+) exchanger (NHE), ethyl-isopropyl amiloride (EIPA), diminishes proliferation of MKN28 human gastric cancer cells by decreasing the cytosolic Cl(-) concentration via DIDS-sensitive pathways.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Antineoplastic Agents; Cell Proliferati | 2012 |